Raymond James Financial Inc. Purchases Shares of 154,351 Aclaris Therapeutics, Inc. (NASDAQ:ACRS)
Raymond James Financial Inc. acquired a new position in shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 154,351 shares of the biotechnology company’s stock, valued at approximately $383,000. A number of other hedge […]
Raymond James Financial Inc. acquired a new position in shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 154,351 shares of the biotechnology company’s stock, valued at approximately $383,000. A number of other hedge […]
